EXACT Sciences Corporation (NASDAQ:EXAS) has climbed 56.94% in the past week and advanced 96.95% in the last 4 weeks. In the past week, the company has outperformed the S&P 500 by 58.82% and the outperformance has advanced to 95.15% for the last 4 weeks period.
EXACT Sciences Corporation (NASDAQ:EXAS): The stock opened at $10.90 on Friday but the bulls could not build on the opening and the stock topped out at $11.28 for the day. The stock traded down to $10.39 during the day, due to lack of any buying support eventually closed down at $10.97 with a loss of -2.49% for the day. The stock had closed at $11.25 on the previous day. The total traded volume was 15,917,974 shares.
The company shares have dropped -64.26% from its 1 Year high price. On Jun 25, 2015, the shares registered one year high at $32.85 and the one year low was seen on Mar 1, 2016. The 50-Day Moving Average price is $6.74 and the 200 Day Moving Average price is recorded at $7.01.
On the companys insider trading activities,The officer (SVP and General Counsel) of Exact Sciences Corp, Coward D Scott sold 1,685 shares at $6.62 on April 1, 2016. The Insider selling transaction had a total value worth of $11,155. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
Many analysts have stated their opinion on the company shares. Craig-Hallum upgrades its view on EXACT Sciences Corporation (NASDAQ:EXAS) according to the research report released by the firm to its investors. The shares have now been rated Buy by the stock experts at the ratings house. Earlier, the shares had a rating of Hold. Craig-Hallum raises the current price target of $18 per share on EXACT Sciences Corporation. The rating by the firm was issued on June 16, 2016. Currently the company Insiders own 5.5% of EXACT Sciences Corporation shares according to the proxy statements. Institutional Investors own 82.05% of EXACT Sciences Corporation shares. During last six month period, the net percent change held by insiders has seen a change of 7.93%.
Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The Company has developed a non?invasive screening test called Cologuard for colorectal cancer. Its Cologuard test is a non?invasive stool?based deoxyribonucleic acid (DNA) (sDNA) screening test designed to detect DNA markers. In addition to DNA markers, its test includes a protein marker to detect blood in the stool, utilizing an antibody?based fecal immunochemical test (FIT). The Companys Cologuard test is designed to detect pre?cancerous lesions or polyps, and each of the four stages of colorectal cancer. By detecting pre?cancers and cancers early with its test, affected patients can be referred to colonoscopy, during which the polyps or lesions can be removed. The companys test also detects blood in stool, utilizing an antibody based FIT test.